Clinical trials
Withdrawn Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Henan Cancer Hospital | 3 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Fudan University | 2 |
| AstraZeneca | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| RemeGen Co., Ltd. | 1 |
| Shandong Cancer Hospital and Institute | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
| Zhi Yang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 13 |
| Lung Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Glioma | 1 |
| Liver Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Pathologic Complete Response | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.